134 related articles for article (PubMed ID: 37827293)
1. Response to Acthar Gel in sarcoidosis uveitis: A prospective open label study.
Ungprasert P; Lowder C; Sharma S; Ribeiro Neto ML; Baran J; Srivastava SK; Culver DA
Respir Med; 2023; 219():107422. PubMed ID: 37827293
[TBL] [Abstract][Full Text] [Related]
2. A retrospective pilot study examining the use of Acthar gel in sarcoidosis patients.
Baughman RP; Barney JB; O'Hare L; Lower EE
Respir Med; 2016 Jan; 110():66-72. PubMed ID: 26626451
[TBL] [Abstract][Full Text] [Related]
3. Pain and Fatigue Improvements in Patients Treated with Repository Corticotropin Injection Across Five Indications: A Narrative Review.
Girman C; Panaccio MP; Hayes K; Niewoehner J; Wan GJ
Adv Ther; 2022 Jul; 39(7):3072-3087. PubMed ID: 35635646
[TBL] [Abstract][Full Text] [Related]
4. Corticosteroid Use and Adherence in Patients Treated with Acthar Gel for Advanced Sarcoidosis.
Hayes K; Niewoehner J; Rice JB; Downes N; Hagopian E; Ma I; Wan GJ
Adv Ther; 2023 Nov; 40(11):4999-5015. PubMed ID: 37728695
[TBL] [Abstract][Full Text] [Related]
5. Results From a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis.
Mirsaeidi M; Baughman RP; Sahoo D; Tarau E
Pulm Ther; 2023 Jun; 9(2):237-253. PubMed ID: 37072607
[TBL] [Abstract][Full Text] [Related]
6. Acthar Gel in African Americans versus Non-African Americans with Symptomatic Sarcoidosis: Physician Assessment of Patient Medical Records.
Bindra J; Chopra I; Hayes K; Niewoehner J; Panaccio MP; Wan GJ
Ther Clin Risk Manag; 2024; 20():83-94. PubMed ID: 38351954
[TBL] [Abstract][Full Text] [Related]
7. Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients.
Riancho-Zarrabeitia L; Calvo-Río V; Blanco R; Mesquida M; Adan AM; Herreras JM; Aparicio Á; Peiteado-Lopez D; Cordero-Coma M; García Serrano JL; Ortego-Centeno N; Maíz O; Blanco A; Sánchez-Bursón J; González-Suárez S; Fonollosa A; Santos-Gómez M; González-Vela C; Loricera J; Pina T; González-Gay MA
Semin Arthritis Rheum; 2015 Dec; 45(3):361-8. PubMed ID: 26092330
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal Dexamethasone Implant for Treatment of Sarcoidosis-Related Uveitis.
Kim M; Kim SA; Park W; Kim RY; Park YH
Adv Ther; 2019 Aug; 36(8):2137-2146. PubMed ID: 31140122
[TBL] [Abstract][Full Text] [Related]
9. Prognosticators for visual outcome in sarcoid uveitis.
Dana MR; Merayo-Lloves J; Schaumberg DA; Foster CS
Ophthalmology; 1996 Nov; 103(11):1846-53. PubMed ID: 8942880
[TBL] [Abstract][Full Text] [Related]
10. Pars plana vitrectomy for vitreous opacity associated with ocular sarcoidosis resistant to medical treatment.
Ieki Y; Kiryu J; Kita M; Tanabe T; Tsujikawa A; Yamashiro K; Miyamoto N; Miura S; Honda Y
Ocul Immunol Inflamm; 2004 Mar; 12(1):35-43. PubMed ID: 15209462
[TBL] [Abstract][Full Text] [Related]
11. Visual loss in sarcoid-related uveitis.
Lobo A; Barton K; Minassian D; du Bois RM; Lightman S
Clin Exp Ophthalmol; 2003 Aug; 31(4):310-6. PubMed ID: 12880455
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of Repository Corticotropin Gel for Ocular Sarcoidosis.
Oh DJ; Singh A; Kanu LN; Lobo-Chan AM; MacIntosh PW; Bhat P
Ocul Immunol Inflamm; 2022 Aug; 30(6):1420-1424. PubMed ID: 33826473
[TBL] [Abstract][Full Text] [Related]
13. Clinical Features of Ocular Sarcoidosis in Patients with Biopsy-proven Pulmonary Sarcoidosis in Serbia.
Radosavljević A; Jakšić V; Pezo L; Kovačević-Pavićević D; Ilić A; Mihailović Vučinić V
Ocul Immunol Inflamm; 2017 Dec; 25(6):785-789. PubMed ID: 27191355
[TBL] [Abstract][Full Text] [Related]
14. Cost-Effectiveness of Acthar Gel versus Standard of Care for the Treatment of Advanced Symptomatic Sarcoidosis.
Bindra J; Chopra I; Hayes K; Niewoehner J; Panaccio M; Wan GJ
Clinicoecon Outcomes Res; 2023; 15():739-752. PubMed ID: 37868649
[TBL] [Abstract][Full Text] [Related]
15. A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes.
Suhler EB; Smith JR; Wertheim MS; Lauer AK; Kurz DE; Pickard TD; Rosenbaum JT
Arch Ophthalmol; 2005 Jul; 123(7):903-12. PubMed ID: 16009830
[TBL] [Abstract][Full Text] [Related]
16. Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients.
Vegas-Revenga N; Calvo-Río V; Mesquida M; Adán A; Hernández MV; Beltrán E; Valls Pascual E; Díaz-Valle D; Díaz-Cordovés G; Hernandez-Garfella M; Martínez-Costa L; Calvo I; Atanes A; Linares LF; Modesto C; González-Vela C; Demetrio-Pablo R; Aurrecoechea E; Cordero M; Domínguez-Casas LC; Atienza-Mateo B; Martín-Varillas JL; Loricera J; Palmou-Fontana N; Hernández JL; González-Gay MA; Blanco R
Am J Ophthalmol; 2019 Apr; 200():85-94. PubMed ID: 30660771
[TBL] [Abstract][Full Text] [Related]
17. [Sarcoid uveitis: Ophthalmologist's and internist's viewpoints].
Sève P; Jacquot R; El Jammal T; Bert A; Jamilloux Y; Kodjikian L; Giorgiutti S
Rev Med Interne; 2023 Mar; 44(3):112-122. PubMed ID: 36642624
[TBL] [Abstract][Full Text] [Related]
18. Pars plana vitrectomy for cystoid macular edema secondary to sarcoid uveitis.
Kiryu J; Kita M; Tanabe T; Yamashiro K; Miyamoto N; Ieki Y
Ophthalmology; 2001 Jun; 108(6):1140-4. PubMed ID: 11382643
[TBL] [Abstract][Full Text] [Related]
19. Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series.
Madan A; Mijovic-Das S; Stankovic A; Teehan G; Milward AS; Khastgir A
BMC Nephrol; 2016 Mar; 17():37. PubMed ID: 27036111
[TBL] [Abstract][Full Text] [Related]
20. Cataract surgery in patients with sarcoidosis-associated uveitis.
Akova YA; Foster CS
Ophthalmology; 1994 Mar; 101(3):473-9. PubMed ID: 8127567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]